Emerging Therapeutic Options for the Management of COPD

被引：10
|
作者：
Reid, Debra J. [1 ]
Pham, Nga T. [1 ]
机构：
[1] Northeastern Univ, Sch Pharm, Dept Pharm Practice, Boston, MA 02115 USA
来源：
CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE | 2013年 / 7卷
关键词：
chronic obstructive pulmonary disease; COPD therapy; long-acting muscarinic agent; phosphodiesterase-4; inhibitor; long-acting beta(2)-agonist;
D O I：
10.4137/CCRPM.S8140
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.
引用
收藏
页码：7 / 15
页数：9
相关论文
共 50 条
  • [1] Emerging Therapeutic Options in Pancreatic Cancer Management
    Delle Cave, Donatella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [2] New therapeutic options in the management of COPD - focus on roflumilast
    Antoniu, Sabina Antonela
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2011, 6 : 147 - 155
  • [3] THERAPEUTIC OPTIONS IN COPD
    CARASSO, B
    GERIATRICS, 1982, 37 (05) : 99 - &
  • [4] Current and emerging therapeutic options for the management of functional dyspepsia
    Vandenberghe, A.
    Schol, J.
    Van den Houte, K.
    Masuy, I.
    Carbone, F.
    Tack, J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (03) : 365 - 376
  • [5] Emerging therapeutic options for the management of hepatitis C infection
    J Richard Thompson
    World Journal of Gastroenterology, 2014, (23) : 7079 - 7088
  • [6] Emerging therapeutic options for the management of hepatitis C infection
    Thompson, J. Richard
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (23) : 7079 - 7088
  • [7] Current and Emerging Therapeutic Options for the Management of Rare Skeletal Diseases
    Semler, Oliver
    Rehberg, Mirko
    Mehdiani, Nava
    Jackels, Miriam
    Hoyer-Kuhn, Heike
    PEDIATRIC DRUGS, 2019, 21 (02) : 95 - 106
  • [8] Current and Emerging Therapeutic Options for the Management of Rare Skeletal Diseases
    Oliver Semler
    Mirko Rehberg
    Nava Mehdiani
    Miriam Jackels
    Heike Hoyer-Kuhn
    Pediatric Drugs, 2019, 21 : 95 - 106
  • [9] Therapeutic options in the management of stable chronic obstructive pulmonary disease (COPD)
    Schäfer, H
    Ewig, S
    Gillissen, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 125 (08) : 230 - 235
  • [10] Emerging therapeutic options in GERD
    Woodland, Philip
    Amarasinghe, Gehanjali
    Sifrim, Daniel
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2013, 27 (03) : 455 - 467
12345